Biochips market 2019-2024 Analyzed by Type – DNA, Protein, Lab-On-Chip and Other (Cellular chips, Tissue chips, Drug of Abuse Chips..)

Highlights

Global Biochips market is projected to grow at about 15% compounded annually from 2010 through 2022. This growth would be driven especially by application of biochips in clinical diagnosis, Drug Development. Biochips are expected to increase the number of drugs released by reducing the time involved in the drug development process, leading to savings in time and costs. Biochips are becoming an essential part of drug discovery process, bolstering efficiency and accuracy. A biochip is a combination of micro fabrication technology and life sciences in a miniaturized device. Small enough to fit the palm of the hand the so-called “lab on a chip” or micro total analysis systems (TAS) employs miniaturization of biological separation and assay techniques to an extent that multiple and complex analyses can be done on a chip.

Fundamentally, biochips are computer-chip look-alikes intended to speedily, reliably, and inexpensively perform biochemical procedures that together constitute a medical test. The far slower, more cumbersome, more expensive laboratory equipment can be replaced by their miniaturization and automation of laboratory procedures. Their current applications lie principally in the analysis of genes for defects or sequence variations. They may soon facilitate screening of molecules for potential usefulness as drugs. The immediate goal is to enable them to serve point-of-care diagnosis. Biochips have become an integral part in the process of drug discovery since the last few years. Biochips market in the global arena is on an upward swing. Biochips which save time in target identification and consequently reduce R & D costs significantly are a boon to drug manufacturing industries.

New drug research uses biochips for drug assays and also to test them for toxicity. This is done so that fewer, or perhaps eventually, no animal testing needs to be done. The concept of personalized medicine is also driving the growth of the demand for biochip. A positive regulatory swing towards use of biochips is anticipated, which may decrease the drug?s time to market and eventually increase monetary inflows. Biochips are playing a key role in clinical diagnosis i.e. they help in diagnosis of disease even before the symptoms are observed Biochips which can identify the presence of different proteins, Nucleic acids, different bacteria etc. in a single analysis help to diagnose the disease.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/905708-biochips-market-research-report

Key Players

Affymetrix, Inc. (USA)

Agilent Technologies, Inc. (USA)

AVIVA Biosciences Corporation (USA)

GE Healthcare (USA)

Thermo Fisher Scientific, Inc. (USA)

More…..

Why buy this Report

This report may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –

• Identify Market Opportunities
• Review and Analyze Global and Regional Markets
• Gauge Market Potential for your Products
• Identify Competition
• Use Market Research for exploring new areas
• Acquire Meaningful Guidelines for Strategic Planning
• Gear up for Market Entry
• Get Actionable Information

Analytics and data presented in each report pertain to several parameters such as –

• Global and Regional Market Sizes, Market Shares, Market Trends
• Product (Global and Regional) Market Sizes, Market Shares, Market Trends
• Technology Trends
• Corporate Intelligence
• Key Companies By Sales, Brands, Products
• Other Strategic Business Affecting Data